Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Lovejoy

Showing results (41-50 of 71) with videos related to

Pageof 8
Sort By:
Journal of Inorganic Biochemistry|September 14, 2013
Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron poolAsikiya Walcourt, Joseph Kurantsin-Mills, John Kwagyan, et al.
Molecular Neurobiology|November 28, 2023
Dysregulation of the Kynurenine Pathway, Cytokine Expression Pattern, and Proteomics Profile Link to Symptomology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Bahar Kavyani, Seong Beom Ahn, Daniel Missailidis, et al.
Neurobiology of Aging|May 6, 2019
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tauKelly R Jacobs, Chai K Lim, Kaj Blennow, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 8, 2012
Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayersZufan Debebe, Sergei Nekhai, Meseret Ashenafi, et al.
Science (New York, N.Y.)|January 21, 1994
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitorB Lovejoy, A Cleasby, A M Hassell, et al.
Journal of Medicinal Chemistry|July 3, 2007
Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agentsDanuta S Kalinowski, Yu Yu, Philip C Sharpe, et al.
Molecular Pharmacology|April 18, 2012
Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effectPatricia Quach, Elaine Gutierrez, Maram Talal Basha, et al.
Cell|May 30, 1998
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25AE B Fauman, J P Cogswell, B Lovejoy, et al.
Biomaterials|July 6, 2010
Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agentsQinghua Miao, Dongxue Xu, Zhi Wang, et al.
Chemical Communications (Cambridge, England)|March 24, 2018
DNA nanoclew templated spherical nucleic acids for siRNA deliveryWeimin Ruan, Meng Zheng, Yang An, et al.
Pageof 8

Showing results (41-50 of 71) with videos related to

Sort By:
Pageof 8
Journal of Inorganic Biochemistry|September 14, 2013
Anti-plasmodial activity of aroylhydrazone and thiosemicarbazone iron chelators: effect on erythrocyte membrane integrity, parasite development and the intracellular labile iron poolAsikiya Walcourt, Joseph Kurantsin-Mills, John Kwagyan, et al.
Molecular Neurobiology|November 28, 2023
Dysregulation of the Kynurenine Pathway, Cytokine Expression Pattern, and Proteomics Profile Link to Symptomology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)Bahar Kavyani, Seong Beom Ahn, Daniel Missailidis, et al.
Neurobiology of Aging|May 6, 2019
Correlation between plasma and CSF concentrations of kynurenine pathway metabolites in Alzheimer's disease and relationship to amyloid-β and tauKelly R Jacobs, Chai K Lim, Kaj Blennow, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|September 8, 2012
Development of a sensitive HPLC method to measure in vitro permeability of E- and Z-isomeric forms of thiosemicarbazones in Caco-2 monolayersZufan Debebe, Sergei Nekhai, Meseret Ashenafi, et al.
Science (New York, N.Y.)|January 21, 1994
Structure of the catalytic domain of fibroblast collagenase complexed with an inhibitorB Lovejoy, A Cleasby, A M Hassell, et al.
Journal of Medicinal Chemistry|July 3, 2007
Design, synthesis, and characterization of novel iron chelators: structure-activity relationships of the 2-benzoylpyridine thiosemicarbazone series and their 3-nitrobenzoyl analogues as potent antitumor agentsDanuta S Kalinowski, Yu Yu, Philip C Sharpe, et al.
Molecular Pharmacology|April 18, 2012
Methemoglobin formation by triapine, di-2-pyridylketone-4,4-dimethyl-3-thiosemicarbazone (Dp44mT), and other anticancer thiosemicarbazones: identification of novel thiosemicarbazones and therapeutics that prevent this effectPatricia Quach, Elaine Gutierrez, Maram Talal Basha, et al.
Cell|May 30, 1998
Crystal structure of the catalytic domain of the human cell cycle control phosphatase, Cdc25AE B Fauman, J P Cogswell, B Lovejoy, et al.
Biomaterials|July 6, 2010
Amphiphilic hyper-branched co-polymer nanoparticles for the controlled delivery of anti-tumor agentsQinghua Miao, Dongxue Xu, Zhi Wang, et al.
Chemical Communications (Cambridge, England)|March 24, 2018
DNA nanoclew templated spherical nucleic acids for siRNA deliveryWeimin Ruan, Meng Zheng, Yang An, et al.
Pageof 8